- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
TORONTO, Canada: According to a recently published report, the ageing population and the growing awareness of available dental treatment options will contribute to a strong expansion of the European market for dental biomaterials. Their use will increase significantly alongside dental implant procedures up to 2021. Revenues are expected to grow to over €287 million (US$375 million).
In particular, they expect Geistlich to remain the leader in the bone-graft substitute segment, which continues to generate the greatest revenue in the European dental biomaterial market. With regard to tissue-regeneration products, Straumann continues to be the only significant competitor.
The high price of dental procedures was identified as one of the main factors hindering growth. Owing to economic concerns, patients, especially in countries with a slow market growth such as Italy and Spain, are more likely to cancel or postpone expensive treatments. However, Sweden is expected to experience the fastest growth in dental biomaterials, as dental implant procedures are partially reimbursed in the country.
The report was issued by the Millennium Research Group, a Canadian market intelligence provider. It contains comprehensive data and analysis on the current state of the market for dental biomaterials in France, Germany, Italy, Spain, Sweden, Switzerland and the UK across a ten-year period.
Thu. 4 April 2024
9:00 pm UTC (London)
Reimagining success with ClearCorrect: From case planning to practice growth
Tue. 9 April 2024
6:00 pm UTC (London)
Soluzioni innovative per sostenere l’evoluzione dello studio: Lo strumento giusto può fare la differenza
Wed. 10 April 2024
12:00 am UTC (London)
ITI US section live treatment planning session
Wed. 10 April 2024
10:00 am UTC (London)
A tooth is extracted—what now? Is there any benefit to ridge augmentation?
Thu. 11 April 2024
1:00 am UTC (London)
Santa Fe Group Medicare Update
Thu. 11 April 2024
8:30 am UTC (London)
Por qué implementar Invisalign Go en tu consulta?
Mon. 15 April 2024
9:00 pm UTC (London)
To post a reply please login or register